Reasons for Early Discontinuation of Targeted Synthetic (ts) or Biologic (b) DMARDs; Chart Review of 20,343 Drug Episodes Given to Patients with Rheumatoid ArthritisKent Kwas Huston, Christopher Adams,Simon Helfgott,Jasvinder Singh,Nehad Soloman, Dan Persons,Scott Milligan,Colin EdgertonARTHRITIS & RHEUMATOLOGY（2022）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
